Bryan Rigg
Corporate Officer/Principal bij University of Cambridge
Profiel
Bryan Rigg is Chief Financial Officer of Healthcare Brands International Ltd.
He is a Faculty Member at the University of Cambridge.
Mr. Rigg has 10 years of experience in healthcare and consumer products.
Prior to joining Healthcare Brands International, he was Director of Group Finance for Amtico Holdings Ltd.
and Vice President of Finance and Legal Affairs for Avon Cosmetics Ltd.
Previously, he held various positions at Boots Healthcare International Ltd.
He is a Chartered Accountant.
Actieve functies van Bryan Rigg
Bedrijven | Functie | Begin |
---|---|---|
University of Cambridge | Corporate Officer/Principal | - |
Eerdere bekende functies van Bryan Rigg
Bedrijven | Functie | Einde |
---|---|---|
Healthcare Brands International Ltd.
Healthcare Brands International Ltd. Pharmaceuticals: MajorHealth Technology Healthcare Brands International (HBI) is a new company, established in the UK in October 2006, and participating primarily in the growing market of OTC Medicines. The company is committed to acquiring, developing and investing in differentiated healthcare products. In short it will translate innovative science into meaningful consumer brands. Funded with over £100 million of venture capital from leading international venture capital investors, the company is a team of experienced OTC blue chip business professionals with an unrivalled network of partners and contacts around the world (with particular strength in Europe). It brings core skills in consumer marketing and brand development and combine with partners providing in-market operational and regulatory expertise. It will focus on innovative products with meaningful and substantiated differentiation that meet a relevant and yet unmet or only partially met consumer need and thereby help grow the overall self-medication market. | Financieel Directeur/CFO | 22-11-2011 |
Reckitt Benckiser Healthcare International Ltd.
Reckitt Benckiser Healthcare International Ltd. Household/Personal CareConsumer Non-Durables Reckitt Benckiser Healthcare International Ltd. manufactures healthcare and beauty products. The company develops & markets analgesics, upper respiratory tract and skincare products. It is headquartered in Nottingham, the United Kingdom. | Corporate Officer/Principal | - |
Avon Cosmetics Ltd.
Avon Cosmetics Ltd. Wholesale DistributorsDistribution Services Avon Cosmetics Ltd. sells beauty and related products. Its product include the Anew, Skin So Soft, and Avon color, The firm also sells jewellery, accessories, gifts, health, fitness and wellbeing products. The company was founded in1959 and located in Northampton, the United Kingdom. | Financieel Directeur/CFO | - |
Opleiding van Bryan Rigg
University of Cambridge | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Reckitt Benckiser Healthcare International Ltd.
Reckitt Benckiser Healthcare International Ltd. Household/Personal CareConsumer Non-Durables Reckitt Benckiser Healthcare International Ltd. manufactures healthcare and beauty products. The company develops & markets analgesics, upper respiratory tract and skincare products. It is headquartered in Nottingham, the United Kingdom. | Consumer Non-Durables |
Avon Cosmetics Ltd.
Avon Cosmetics Ltd. Wholesale DistributorsDistribution Services Avon Cosmetics Ltd. sells beauty and related products. Its product include the Anew, Skin So Soft, and Avon color, The firm also sells jewellery, accessories, gifts, health, fitness and wellbeing products. The company was founded in1959 and located in Northampton, the United Kingdom. | Distribution Services |
Healthcare Brands International Ltd.
Healthcare Brands International Ltd. Pharmaceuticals: MajorHealth Technology Healthcare Brands International (HBI) is a new company, established in the UK in October 2006, and participating primarily in the growing market of OTC Medicines. The company is committed to acquiring, developing and investing in differentiated healthcare products. In short it will translate innovative science into meaningful consumer brands. Funded with over £100 million of venture capital from leading international venture capital investors, the company is a team of experienced OTC blue chip business professionals with an unrivalled network of partners and contacts around the world (with particular strength in Europe). It brings core skills in consumer marketing and brand development and combine with partners providing in-market operational and regulatory expertise. It will focus on innovative products with meaningful and substantiated differentiation that meet a relevant and yet unmet or only partially met consumer need and thereby help grow the overall self-medication market. | Health Technology |